Chiesi Farmaceutica

Protalix to propose virtual inspection to clear barrier to FDA approval
Biopharma Reporter
Thu, 05/20/21 - 11:10 am
Protalix BioTherapeutics
Chiesi Farmaceutica
Fabry disease
FDA
Triple inhaler reduces COPD flare-ups by 20%
Drug Delivery Business News
Thu, 04/6/17 - 09:30 am
COPD
triple inhaler
Chiesi Farmaceutica